Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ)
CNY 5.88
(-0.34%)
CNY 5.88
(-0.34%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 382.95 Million CNY | 67.69% |
| 2022 | 228.36 Million CNY | 32.9% |
| 2021 | 171.82 Million CNY | 27.83% |
| 2020 | 134.41 Million CNY | -55.47% |
| 2019 | 301.84 Million CNY | 9.79% |
| 2018 | 274.93 Million CNY | -17.34% |
| 2017 | 332.6 Million CNY | 2.31% |
| 2016 | 325.1 Million CNY | -0.86% |
| 2015 | 327.91 Million CNY | -20.0% |
| 2014 | 409.9 Million CNY | 15.79% |
| 2013 | 354 Million CNY | 32.79% |
| 2012 | 266.59 Million CNY | 46.09% |
| 2011 | 182.48 Million CNY | 41.2% |
| 2010 | 129.23 Million CNY | 96.66% |
| 2009 | 65.71 Million CNY | 9.86% |
| 2008 | 59.81 Million CNY | 50.24% |
| 2007 | 39.81 Million CNY | 122.78% |
| 2006 | 17.87 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 87.42 Million CNY | 28.47% |
| 2024 Q2 | 68.05 Million CNY | -32.71% |
| 2024 Q1 | 101.14 Million CNY | -29.81% |
| 2023 Q1 | 95.96 Million CNY | 14.18% |
| 2023 Q4 | 144.1 Million CNY | 92.21% |
| 2023 FY | 382.95 Million CNY | 67.69% |
| 2023 Q3 | 74.97 Million CNY | 10.38% |
| 2023 Q2 | 67.91 Million CNY | -29.23% |
| 2022 Q4 | 84.04 Million CNY | 91.13% |
| 2022 Q1 | 68.73 Million CNY | 142.26% |
| 2022 Q2 | 31.61 Million CNY | -54.0% |
| 2022 Q3 | 43.97 Million CNY | 39.09% |
| 2022 FY | 228.36 Million CNY | 32.9% |
| 2021 FY | 171.82 Million CNY | 27.83% |
| 2021 Q4 | 28.37 Million CNY | -34.05% |
| 2021 Q1 | 68.24 Million CNY | 1320.53% |
| 2021 Q3 | 43.02 Million CNY | 33.67% |
| 2021 Q2 | 32.18 Million CNY | -52.84% |
| 2020 Q2 | 32.05 Million CNY | -48.62% |
| 2020 FY | 134.41 Million CNY | -55.47% |
| 2020 Q4 | 4.8 Million CNY | -86.34% |
| 2020 Q3 | 35.17 Million CNY | 9.75% |
| 2020 Q1 | 62.38 Million CNY | 3.64% |
| 2019 FY | 301.84 Million CNY | 9.79% |
| 2019 Q4 | 60.18 Million CNY | -1.66% |
| 2019 Q3 | 61.2 Million CNY | -36.37% |
| 2019 Q2 | 96.18 Million CNY | 14.16% |
| 2019 Q1 | 84.25 Million CNY | 1255.21% |
| 2018 Q3 | 65.6 Million CNY | -34.33% |
| 2018 FY | 274.93 Million CNY | -17.34% |
| 2018 Q4 | -7.29 Million CNY | -111.12% |
| 2018 Q1 | 116.73 Million CNY | 486.94% |
| 2018 Q2 | 99.88 Million CNY | -14.43% |
| 2017 Q1 | 110.02 Million CNY | 404.01% |
| 2017 Q3 | 81 Million CNY | -33.43% |
| 2017 Q4 | 19.88 Million CNY | -75.45% |
| 2017 FY | 332.6 Million CNY | 2.31% |
| 2017 Q2 | 121.68 Million CNY | 10.6% |
| 2016 Q1 | 97.41 Million CNY | 162.45% |
| 2016 Q3 | 81.38 Million CNY | -34.62% |
| 2016 Q4 | 21.83 Million CNY | -73.18% |
| 2016 FY | 325.1 Million CNY | -0.86% |
| 2016 Q2 | 124.47 Million CNY | 27.77% |
| 2015 FY | 327.91 Million CNY | -20.0% |
| 2015 Q4 | 37.11 Million CNY | -48.91% |
| 2015 Q3 | 72.65 Million CNY | -36.27% |
| 2015 Q2 | 113.99 Million CNY | 9.46% |
| 2015 Q1 | 104.14 Million CNY | 10.7% |
| 2014 Q4 | 94.08 Million CNY | -9.48% |
| 2014 Q3 | 103.93 Million CNY | -12.2% |
| 2014 Q2 | 118.38 Million CNY | 26.62% |
| 2014 FY | 409.9 Million CNY | 15.79% |
| 2014 Q1 | 93.49 Million CNY | 20.1% |
| 2013 Q1 | 79.46 Million CNY | 20.76% |
| 2013 FY | 354 Million CNY | 32.79% |
| 2013 Q4 | 77.85 Million CNY | -19.35% |
| 2013 Q3 | 96.53 Million CNY | -3.62% |
| 2013 Q2 | 100.16 Million CNY | 26.06% |
| 2012 Q1 | 59.41 Million CNY | 40.35% |
| 2012 Q2 | 66.88 Million CNY | 12.58% |
| 2012 Q3 | 74.49 Million CNY | 11.38% |
| 2012 Q4 | 65.8 Million CNY | -11.67% |
| 2012 FY | 266.59 Million CNY | 46.09% |
| 2011 Q2 | 45.65 Million CNY | 10.6% |
| 2011 FY | 182.48 Million CNY | 41.2% |
| 2011 Q4 | 42.33 Million CNY | -20.46% |
| 2011 Q1 | 41.27 Million CNY | 30.84% |
| 2011 Q3 | 53.21 Million CNY | 16.57% |
| 2010 Q1 | 18.78 Million CNY | 127.3% |
| 2010 Q4 | 31.54 Million CNY | -39.09% |
| 2010 Q3 | 51.79 Million CNY | 91.01% |
| 2010 FY | 129.23 Million CNY | 96.66% |
| 2010 Q2 | 27.11 Million CNY | 44.34% |
| 2009 Q3 | 21.66 Million CNY | 2.75% |
| 2009 Q4 | 8.26 Million CNY | -61.85% |
| 2009 FY | 65.71 Million CNY | 9.86% |
| 2009 Q2 | 21.08 Million CNY | 43.37% |
| 2009 Q1 | 14.7 Million CNY | -21.27% |
| 2008 Q4 | 18.67 Million CNY | 76.09% |
| 2008 FY | 59.81 Million CNY | 50.24% |
| 2008 Q3 | 10.6 Million CNY | 0.0% |
| 2007 FY | 39.81 Million CNY | 122.78% |
| 2006 FY | 17.87 Million CNY | 0.0% |